New research to be published in tomorrow’s issue of the Journal of the American Medical Association (JAMA) (Vol. 302, No. 11), by a team at The Cancer Institute of New Jersey (CINJ), shows that men diagnosed with prostate cancer beginning in [...] Read more »

Experts at The University of Nottingham are working on ground-breaking research to determine, for the first time, precisely what damage obesity can inflict on the muscles in our body. It is hoped their research, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), will lead to more effective treatment strategies for [...] Read more »

Today sees the launch of a new report called Testing targets: findings from the United Kingdom Gay Men’s Sex Survey 2007. The survey was carried out by Sigma Research and commissioned by Terrence Higgins Trust (THT), on behalf of the CHAPS partnership. It is the largest survey of its kind in the world, with over [...] Read more »

Virginia Commonwealth University School of Medicine researchers have discovered a gene involved with the production of sperm that may contribute to male infertility and lead to new approaches to male contraception. One in six couples trying to conceive a baby is affected by infertility, according to the American Fertility Association – and [...] Read more »

Older men whose localized prostated cancer is not aggressively treated with surgery or radiation but follows a conservative management regime also known as “watchful waiting” are surviving longer, according to a new US study. These are the conclusions of Senior author Dr Grace L.

Read The Full Article…Prostate Cancer [...] Read more »

Male circumcision among heterosexual men in low male circumcision, high HIV prevalence settings is beneficial and cost effective, says a new article in the open access journal PLoS Medicine. Male circumcision should be considered as [...] Read more »

Clinical Infectious Diseases Examines Relationship Between HIV, Nutrition, Food Insecurity “Despite calls from national and international organizations to integrate HIV and nutritional programs, data are lacking on how such programs can be effectively implemented in resource-poor settings, on the optimum content and duration of nutritional support, and on ideal [...] Read more »

An FDA panel on Wednesday recommended that the agency approve GlaxoSmithKline’s human papillomavirus vaccine, Cervarix, to prevent cervical cancer, as well as expand approval of Merck’s HPV vaccine, Gardasil, to include use in men ages nine to 26 for the prevention of genital warts, the Wall Street Journal reports.

Read The Full Article…FDA Panel Recommends Approval [...] Read more »

Growing evidence shows that exposure to lead in the environment is associated with cardiovascular disease, including increased risk of hypertension. However, those studies have looked at lead concentrations in blood, not bone lead, a better indicator of cumulative lead exposure over time.

Read The Full Article…Lead In Bone Associated With Increased Risk Of Death From Cardiovascular [...] Read more »

Merck & Co., Inc. announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through [...] Read more »